Lower dose of heated chemo may be just as effective for rare abdominal cancer
NCT ID NCT06513065
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a lower dose of heated chemotherapy given during surgery works as well as a higher dose for people with pseudomyxoma peritonei, a rare cancer that spreads in the abdomen. About 176 participants will be randomly assigned to receive either the lower dose over 60 minutes or the higher dose over 90 minutes. The goal is to see if the lower dose can control the cancer just as well while causing fewer side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Mitomycin C (heated chemotherapy given during surgery)
What this could lead to
If the lower dose works as well, it could mean fewer complications for patients while still controlling the cancer effectively.
What could go wrong
This is a single study with 176 participants, so results may not apply to everyone. The lower dose might be less effective at preventing cancer return.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSEUDOMYXOMA PERITONEI are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peritoneal Malignancy Institute Basingstoke - Hampshire Hospitals NHS Foundation Trust
RECRUITINGBasingstoke, Hampshire, United Kingdom
Contact
Contact
Contact Email: •••••@•••••
Contact
Contact
Contact
Contact Email: •••••@•••••
Contact
Contact
Contact